Wednesday, February 04, 2026 Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialMoraes FY, Isen J, Perry J, Laperriere N, Brandes A, Menten J, Phillips C, Fay M, Nishikawa R, Mason WP, Cairncross JG, Roa W, Ding K, O’Callaghan C. Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial. Journal of Neuro-Oncology 176: 171. 2026.https://doi.org/10.1007/s11060-025-05399-x Glioblastoma (GB) in the elderly is associated with poor prognosis and outcome heterogeneity. Researchers aimed to develop and validate prognostic nomograms for elderly GB patients using data from the CCTG CE.6 trial. Trial-based nomograms were developed and validated for elderly GB patients, effectively stratifying risk and predicting survival. These tools may guide individualized prognostication, inform treatment decisions, and improve trial design in this underrepresented population.
